• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services


  • Print
  • Share
  • E-mail

Agenerase (amprenavir)

Health professionals are notified of important changes to the labeling for Agenerase Oral Solution. These changes highlight the potential risks, associated with the large amount of the excipient propylene glycol in Agenerase Oral Solution.

[May 1, 2000 - Letter - GlaxoWellcome]